ישראל - עברית - Ministry of Health

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 20 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 15 mg - buprenorphine

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - clindamycin as hydrochloride - תמיסה (פומי) - clindamycin as hydrochloride 25 mg / 1 ml

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - טבליות מצופות - sirolimus 1 mg - sirolimus

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - טבליות מצופות - sirolimus 1 mg - sirolimus

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - clonazepam - טבליה - clonazepam 2 mg - clonazepam - clonazepam - typical or atypical petit mal, lennox - gastaut syndrome (petit mal variant), generalized primary or secondary tonic-clonic seizures including grand mal and focal seizures. panic disorder.

ישראל - עברית - Ministry of Health

teva israel ltd - clonazepam - טבליה - clonazepam 0.5 mg - clonazepam

ישראל - עברית - Ministry of Health

teva israel ltd - clonazepam - טבליה - clonazepam 2 mg - clonazepam

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 100 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 50 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai